Ulcerative Colitis
Conditions
Keywords
Gastrointestinal Motility, Inflammatory Bowel Disease, Transit time
Brief summary
The purpose of this study is to describe gastrointestinal (GI) motility in patients suffering from severe Ulcerative Colitis (UC) and to compare these results with similar results obtained in remission. The study is done with the use of Motilis 3D-Transit system which consists of a small electronic capsule ingested and detected by a receiver carried by the patient. Position and orientation of the capsule are interpreted by dedicated computer software and transit times, progression velocity and contraction frequencies can be revealed. The study is mainly descriptive and is designed to test and evaluate the usefulness of the Motilis 3D Transit system in UC patients and to tell investigators more about GI motility during and after severe inflammation. Motilis 3D-Transit system gives investigators a unique chance to study the gastrointestinal canal as a whole during and after severe illness. The investigators expect to include 20 patients suffering from severe UC admitted to Hospital with the purpose of getting medical treatment. The investigators do not expect any drop out, but in case of drop out a new patient will be included.
Interventions
DEVICEMotilis-3D-transit
Sponsors
Motilis Medica A/S ,Switzerland
University of Aarhus
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Severe Ulcerative colitis (modified Truelove and Witt score) * Signed informed consent obtained * Fasted since midnight
Exclusion criteria
* Known GI related symptoms complaints or GI diseases * Swallowing disorders * Cancer or other life threatening diseases or conditions * Pregnancy or breast-feeding * Previous abdominal surgery * Abdominal diameter \>140cm? * Drug abuse or alcoholism * Irregular bowel movements * Known cardiovascular or pulmonary diseases * Participation in any clinical study within the last 30 days * Cardiac pacemaker or infusion pump or any other implanted or portable electro-mechanical medical device. * Medication affecting GI motility * MRI within the next four weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Velocity of progression through the inflamed part of the colon in severe UC compared to the velocity of progression in the corresponding colonic segment in quiescent UC. | Three days from baseline visit |
Secondary
| Measure | Time frame |
|---|---|
| Velocity of progression through the non-inflamed colonic segments in severe UC compared to the velocity of progression in the corresponding colonic segments in quiescent UC. | Three days from baseline |
Other
| Measure | Time frame |
|---|---|
| Velocity of progression through the colonic segments in quiescent UC compared to the velocity of progression in the corresponding colonic segments in healthy volunteers. | three days from baseline visit |
Countries
Denmark
Contacts
Primary ContactAnneMette Haase, ph.d student
Backup ContactKlaus Krogh, Professor
Outcome results
None listed